News

Investment from largest shareholder strengthens balance sheet, signals insider conviction, and funds Telomir-1’s upcoming IND submission for a rare disease indication ...
For the first time, doctors have treated an infant with a rare genetic disease with a gene-editing therapy tailored ...
Applied Therapeutics’ rare disease drug has failed another late-stage clinical trial, adding to the woes of a candidate that ...
An infant in Philadelphia has been successfully treated with a customized Crispr gene-editing therapy for a rare and deadly ...
This spring at CHU Sainte-Justine, an 18-year-old patient with a rare disease called chronic granulomatous disease (CGD) became the first person ever to receive next-generation gene therapy known as ...
While sparking excitement among biopharma companies focused on rare and ultrarare indications, experts say FDA Commissioner ...
President Trump recently signed a wide-ranging executive order urging Congress to amend a crucial provision of a Biden-era ...
Doctors have successfully used gene-editing therapy to treat an infant born with a rare disorder. Experts believe the ...
When an Omaha woman was diagnosed with a rare illness as a teenager, it affected not only her health but also her high school ...
Creutzfeldt-Jakob disease (CJD) is a rare and fatal condition that affects the human brain, causing brain damage that worsens ...
A San Francisco boy with a rare bone marrow disease has been on the waitlist for more than a year. Gia Vang reports. A San ...
A personalized gene editing therapy was successfully used to treat an infant with CPS1 deficiency, a disease that causes ...